Delivery Order SPE2DB22D1106-SPE2DB24FERE4
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
- This federal contract award, valued at $32,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm-fixed price delivery order contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024, and does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award, valued at $7,097.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $3,353.77, is for STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The contract has an ultimate completion date of January 29, 2024....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,231.97 for the supply of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has a completion date of December 22, 2023 and was awarded on December 21, 2023. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and equipment to military healthcare programs. This award is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,337.31 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, with a completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,364.50, is for the delivery of the pharmaceutical product Stelara 45 mg/0.5 ml syringe, 0.5 ml. This is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of May 7, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,987.20, is a delivery order for the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,568.40, is for the delivery of STELARA 90 MG/ML SYRINGE/ML medication and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $20,944.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award has an ultimate completion date of April 24, 2023 and is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FERE4Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an award value of $8,101.84 and covers the delivery of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of May 10, 2024. Amerisourcebergen Drug Corp has an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 5/9/24 |